Boehringer Ingelheim Animal Health USA Inc — Federal Contractor Profile
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC: $7.9 Million in Federal Contracts Over Years
Contractor Overview
Total Contract Value: $7,877,030 ($7.9M)
Total Awards: 2
Company Profile
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC is a leading global pharmaceutical company specializing in animal health solutions. The company's core capabilities include the development, manufacturing, and distribution of veterinary medicines, vaccines, and diagnostic products. Their extensive product portfolio addresses a wide range of animal health issues, from infectious diseases to nutritional support. BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has a long-standing relationship with the U.S. government, providing critical animal health products and services to various agencies. However, the company has not secured any new government contracts in recent years, indicating a stable but potentially declining business in this sector. The company's government business is relatively small, with a total contract value of $7.9 million over the past few years, and they have not engaged in any sole-source contracts, suggesting a focus on competitive bidding processes. Their track record includes delivering high-quality products and services, but the lack of recent contracts and the absence of specific agency clients highlight potential risks and opportunities for the company. BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC's business strategy appears to be centered on maintaining its existing client base and leveraging its strong brand reputation in the animal health industry.
Specializations
- Veterinary medicines
- Vaccines
- Diagnostic products
- Infectious disease control
- Nutritional support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC holds a dominant position in the animal health sector, offering a comprehensive range of products and services. They are a well-established player with a strong brand reputation and a proven track record of delivering high-quality solutions. However, the lack of recent contracts and the absence of specific agency clients suggest that they may face challenges in maintaining their market share and securing new business opportunities.
Value to Taxpayers
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC provides good value for taxpayer money, given their competitive history and the quality of their products and services. Their average contract size of $3,938,515 is within industry norms, and their focus on competitive bidding processes ensures that they remain accountable to taxpayers. However, the absence of recent contracts and the lack of specific agency clients may indicate potential risks in terms of cost and performance.
Agency Relationships
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has a stable relationship with various government agencies, but the absence of specific agency clients and recent contracts suggests a lack of dependency on any single agency. This could be a risk if the company fails to secure new contracts, as it may struggle to maintain its current level of business.
Red Flags
- No recent contracts: The company has not secured any new government contracts in recent years, which could indicate a decline in demand or challenges in securing new business.
- Lack of specific agency clients: The absence of specific agency clients suggests a lack of dependency on any single agency, which could be a risk if the company fails to secure new contracts.
- Stable but potentially declining business: The company's government business is relatively small and stable, but there is a risk of further decline if they do not secure new contracts.
Green Flags
- Strong brand reputation: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has a strong brand reputation in the animal health industry, which can help them maintain their market position.
- Competitive bidding processes: The company's focus on competitive bidding processes ensures that they remain accountable to taxpayers and maintain high standards of performance.
- Comprehensive product portfolio: Their extensive product portfolio addresses a wide range of animal health issues, making them a valuable partner for government agencies.
Key Contracts
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has secured a total of $7.9 million in government contracts over the past few years. While the company has not secured any new contracts in recent years, their existing contracts involve the provision of high-quality veterinary medicines, vaccines, and diagnostic products. These contracts highlight the company's core capabilities and its ability to deliver reliable and effective solutions to government agencies. The lack of recent contracts and the absence of specific agency clients suggest that the company may face challenges in maintaining its current level of business. However, their strong brand reputation and comprehensive product portfolio make them a valuable partner for government agencies, and their focus on competitive bidding processes ensures that they remain accountable to taxpayers.
Frequently Asked Questions
What does BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC do for the federal government?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC provides the U.S. government with a wide range of veterinary medicines, vaccines, and diagnostic products to support animal health. Their core capabilities include the development, manufacturing, and distribution of products that address various animal health issues, from infectious diseases to nutritional support.
How much taxpayer money does BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC receive?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has secured a total of $7.9 million in government contracts over the past few years. While they have not secured any new contracts in recent years, their average contract size is $3,938,515, which is within industry norms.
Is BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC good value for taxpayer money?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC provides good value for taxpayer money, given their competitive history and the quality of their products and services. Their average contract size of $3,938,515 is within industry norms, and their focus on competitive bidding processes ensures that they remain accountable to taxpayers. However, the absence of recent contracts and the lack of specific agency clients may indicate potential risks in terms of cost and performance.
How does BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC win its contracts?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC primarily wins its contracts through competitive bidding processes. They have not engaged in any sole-source contracts, which suggests that they are committed to maintaining high standards of accountability and performance. Their strong brand reputation and comprehensive product portfolio also contribute to their ability to secure contracts.
What agencies use BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC most?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC has a stable relationship with various government agencies, but the absence of specific agency clients suggests a lack of dependency on any single agency. This could be a risk if the company fails to secure new contracts, as it may struggle to maintain its current level of business.
What are the risks of relying on BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC?
The risks of relying on BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC include the lack of recent contracts and the absence of specific agency clients, which could indicate a decline in demand or challenges in securing new business. Additionally, the company's stable but potentially declining business in the government sector could pose a risk if they fail to maintain their current level of business.
How does BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC compare to similar contractors?
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC holds a dominant position in the animal health sector, offering a comprehensive range of products and services. They are a well-established player with a strong brand reputation and a proven track record of delivering high-quality solutions. However, the lack of recent contracts and the absence of specific agency clients suggest that they may face challenges in maintaining their market share and securing new business opportunities.
Recent Federal Contracts
Boehringer Ingelheim Animal Health USA Inc has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| USDA awards $3.9M for oral rabies vaccine baits to Boehringer Ingelheim Anima... | Department of Agriculture | $3.9M | N/A |